{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:20:49Z","timestamp":1772191249460,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11934-014-0459-5","type":"journal-article","created":{"date-parts":[[2014,10,6]],"date-time":"2014-10-06T04:29:33Z","timestamp":1412569773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["2013-2014 Updates in Peyronie\u2019s Disease Management"],"prefix":"10.1007","volume":"15","author":[{"given":"Benjamin A.","family":"Sherer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnan","family":"Warrior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"key":"459_CR1","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01781.x","volume":"7","author":"D Ralph","year":"2010","unstructured":"Ralph D, Gonzalez-Cadavid N, Mirone V, et al. The medical management of Peyronie\u2019s disease: Evidence-based 2010 guidelines. J Sex Med. 2010;7:2359\u201374. A collaboration of international experts established evidence-based guidelines in the management in of PD.","journal-title":"J Sex Med"},{"key":"459_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","volume":"14","author":"F Sommer","year":"2002","unstructured":"Sommer F, Schwartzer U, Wassmer G, et al. Epidemiology of Peyronie\u2019s disease. Int J Impot Res. 2002;14:379\u201383.","journal-title":"Int J Impot Res"},{"key":"459_CR3","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"JP Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie\u2019s disease. J Urol. 2006;175:2115\u20138.","journal-title":"J Urol"},{"key":"459_CR4","doi-asserted-by":"crossref","first-page":"282503","DOI":"10.1155\/2011\/282503","volume":"2011","author":"DB DiBenedetti","year":"2011","unstructured":"DiBenedetti DB, Nguyen D, Zografos L, et al. A population-based study of Peyronie's disease: prevalence and treatment patterns in the United States. Adv Urol. 2011;2011:282503.","journal-title":"Adv Urol"},{"key":"459_CR5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bju.12565","volume":"113","author":"CC Carson","year":"2014","unstructured":"Carson CC, Levine LA. Outcomes of surgical treatment of Peyronie's disease. BJU Int. 2014;113:704\u201313.","journal-title":"BJU Int"},{"key":"459_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1743-6109.2012.03003.x","volume":"10","author":"LA Levine","year":"2013","unstructured":"Levine LA, Burnett AL. Standard operating procedures for Peyronie's disease. J Sex Med. 2013;10:230\u201344.","journal-title":"J Sex Med"},{"key":"459_CR7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/B978-1-4160-6911-9.00028-1","volume-title":"Campbell-Walsh Urology","author":"GH Jordan","year":"2012","unstructured":"Jordan GH, McCammon KA. Peyronie\u2019s disease. In: Wein AJ et al., editors. Campbell-Walsh Urology, vol. 1. 10th ed. Philadelphia: Saunders; 2012. p. 792\u2013809.","edition":"10"},{"key":"459_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/aja.2012.92","volume":"15","author":"LA Levine","year":"2013","unstructured":"Levine LA, Larsen SM. Surgery for Peyronie\u2019s disease. Asian J Androl. 2013;15:27\u201334.","journal-title":"Asian J Androl"},{"key":"459_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11934-014-0415-4","volume":"15","author":"RB Tan","year":"2014","unstructured":"Tan RB, Sangkum P, Mitchell GC, et al. Update on medical management of Peyronie's disease. Curr Urol Rep. 2014;15:415.","journal-title":"Curr Urol Rep"},{"key":"459_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11845-013-1036-5","volume":"183","author":"U Ozturk","year":"2014","unstructured":"Ozturk U, Yesil S, Goktug HN, et al. Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction. Ir J Med Sci. 2014;183:449\u201353. PDE5 inhibitors can be used in combination therapy for PD and may lead to objective improvements beyond erectile function.","journal-title":"Ir J Med Sci"},{"key":"459_CR11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1095\/biolreprod.106.059642","volume":"76","author":"MG Ferrini","year":"2007","unstructured":"Ferrini MG, Kovanecz I, Sanchez S, et al. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol Reprod. 2007;76:915\u201323.","journal-title":"Biol Reprod"},{"key":"459_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","volume":"9","author":"EGA Valente","year":"2003","unstructured":"Valente EGA, Vernet D, Ferrini MG, et al. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie\u2019s fibrotic plaque and related fibroblast cultures. Nitric Oxide. 2003;9:229\u201344.","journal-title":"Nitric Oxide"},{"key":"459_CR13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.2047-2927.2012.00007.x","volume":"1","author":"G Paulis","year":"2013","unstructured":"Paulis G, Brancato T, D'ascenzo R, et al. Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases. Andrology. 2013;1:120\u20138.","journal-title":"Andrology"},{"key":"459_CR14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-5347(17)67832-7","volume":"71","author":"GH Teasley","year":"1954","unstructured":"Teasley GH. Peyronie's disease; a new approach. J Urol. 1954;71:611\u20134.","journal-title":"J Urol"},{"key":"459_CR15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-5347(17)67602-X","volume":"72","author":"H Bodner","year":"1954","unstructured":"Bodner H, Howard AH, Kaplan JH. Peyronle's disease: cortisone-hyaluronidase-hydrocortisone therapy. J Urol. 1954;72:400\u20133.","journal-title":"J Urol"},{"key":"459_CR16","unstructured":"Jardin A, Wagner G, Khoury S, et al. Erectile dysfunction. In: First International Consultation of Erectile Dysfunction. Co-sponsored by World Health Organization, International Society for Impotence Research, and Societe Internationale d\u2019Urologie, Paris, July 1-3, 1999."},{"key":"459_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0022-4804(90)90197-A","volume":"49","author":"RC Lee","year":"1990","unstructured":"Lee RC, Ping JA. Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J Surg Res. 1990;49:463\u20136.","journal-title":"J Surg Res"},{"key":"459_CR18","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1073\/pnas.93.11.5478","volume":"93","author":"M Roth","year":"1996","unstructured":"Roth M, Eickelberg O, Kohler E, Erne P, Block LH. Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci U S A. 1996;93:5478\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"459_CR19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0022-5347(01)64224-1","volume":"158","author":"LA Levine","year":"1997","unstructured":"Levine LA. Treatment of Peyronie's disease with intralesional verapamil injection. J Urol. 1997;158:1395\u20139.","journal-title":"J Urol"},{"key":"459_CR20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","volume":"69","author":"NE Bennett","year":"2007","unstructured":"Bennett NE, Guhring P, Mulhall JP. Intralesional verapamil prevents the progression of Peyronie's disease. Urology. 2007;69:1181\u20134.","journal-title":"Urology"},{"key":"459_CR21","author":"V Favilla","year":"2013","unstructured":"Favilla V, Russo GI, Privitera S, et al. Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study [published online ahead of print October 11 2013]. Andrologia. 2013. doi: 10.1111\/and.12178 . This small RCT supports the efficacy of ILI verapamil, which leads to notable improvement in penile curvature and decreases in PD plaque volume. Adding oral antioxidants to ILI regimen seems to improve pain symptoms.","journal-title":"Andrologia"},{"key":"459_CR22","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/01.ju.0000056153.47716.d0","volume":"169","author":"LA Levine","year":"2003","unstructured":"Levine LA, Estrada CR, Shou W, et al. Tunica albuginea tissue analysis after electromotive drug administration. J Urol. 2003;169:1775\u20138.","journal-title":"J Urol"},{"key":"459_CR23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.ju.0000116450.82816.2c","volume":"171","author":"SM Stasi Di","year":"2004","unstructured":"Di Stasi SM, Giannantoni A, Stephen RL, et al. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. J Urol. 2004;171:1605\u20138.","journal-title":"J Urol"},{"key":"459_CR24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.juro.2006.10.065","volume":"177","author":"JM Greenfield","year":"2007","unstructured":"Greenfield JM, Shah SJ, Levine LA. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. J Urol. 2007;177:972\u20135.","journal-title":"J Urol"},{"key":"459_CR25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.2047-2927.2012.00018.x","volume":"1","author":"AR Mehrsai","year":"2013","unstructured":"Mehrsai AR, Namdari F, Salavati A, et al. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease. Andrology. 2013;1:129\u201332. This prospective trial supports use of TEA verapamil, showing similar improvements in curvature compared to ILI verapamil with less associated pain.","journal-title":"Andrology"},{"key":"459_CR26","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/jsm.12312","volume":"10","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Hellstrom WJ, Mcmahon CG, et al. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease. J Sex Med. 2013;10:2822\u201331. This report provides baseline patient characteristics of patients included in the large scale, phase III IMPRESS I and II trials.","journal-title":"J Sex Med"},{"key":"459_CR27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207. This large-scale RCT reveals strong support for ILI CCH in stabilized PD. Results at 52\u00a0weeks, show significant improvement in curvature (50.1\u00b0 to 33.1\u00b0) and PDQ scores. ILI CCH (Xiaflex\u2122) obtained FDA approval for use in chronic phase PD in December 2013.","journal-title":"J Urol"},{"key":"459_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2012.10.049","volume":"63","author":"CS Lin","year":"2013","unstructured":"Lin CS, Lue TF. Adipose-derived stem cells for the treatment of Peyronie's disease? Eur Urol. 2013;63:561\u20132. This small in vivo trial using a rat model of PD suggests that ADSC injection in the early acute phase of PD may prevent development of penile plaque formation.","journal-title":"Eur Urol"},{"key":"459_CR29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eururo.2012.09.034","volume":"63","author":"F Castiglione","year":"2013","unstructured":"Castiglione F, Hedlund P, Van der aa F, et al. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease. Eur Urol. 2013;63:551\u201360. This study provides further support for ADSC injection as a means of preventing penile plaque in a rat model, and also demonstrates improvement in erectile function after ADSC injection.","journal-title":"Eur Urol"},{"key":"459_CR30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/01.ju.0000108060.30363.8d","volume":"171","author":"EW Hauck","year":"2004","unstructured":"Hauck EW, Mueller UO, Bschleipfer T, et al. Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials. J Urol. 2004;171:740\u20135.","journal-title":"J Urol"},{"key":"459_CR31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","volume":"56","author":"A Palmieri","year":"2009","unstructured":"Palmieri A, Imbimbo C, Longo N, et al. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. Eur Urol. 2009;56:363\u20139.","journal-title":"Eur Urol"},{"key":"459_CR32","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1743-6109.2012.02677.x","volume":"9","author":"JP Mulhall","year":"2012","unstructured":"Mulhall JP, Hall M, Broderick GA, Incrocci L. Radiation Therapy in Peyronie\u2019s Disease. J Sex Med. 2012;9:1435\u201341.","journal-title":"J Sex Med"},{"key":"459_CR33","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1464-410X.2010.09331.x","volume":"106","author":"S Chitale","year":"2010","unstructured":"Chitale S, Morsey M, Swift L, Sethia K. Limited shock wave therapy vs sham treatment in men with Peyronie\u2019s disease: results of a prospective randomized controlled double-blind trial. BJU Int. 2010;106:1352\u20136.","journal-title":"BJU Int"},{"key":"459_CR34","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/jsm.12275","volume":"10","author":"G Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Meisner C, Gschwend JE, et al. Extracorporeal shock wave therapy in Peyronie\u2019s disease: results of a placebo-controlled, prospective, randomized single-blind study. J Sex Med. 2013;10:2815\u201321. This recent prospective randomized trial confirms no efficacy for ESWT as a treatment modality for PD.","journal-title":"J Sex Med"},{"key":"459_CR35","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","volume":"5","author":"LA Levine","year":"2008","unstructured":"Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study. J Sex Med. 2008;5:1468\u201373.","journal-title":"J Sex Med"},{"key":"459_CR36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2008.01108.x","volume":"6","author":"P Gontero","year":"2009","unstructured":"Gontero P, Di Marco M, Giubilei G, et al. Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study. J Sex Med. 2009;6:558\u201366.","journal-title":"J Sex Med"},{"key":"459_CR37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1743-6109.2011.02519.x","volume":"9","author":"MR Abern","year":"2012","unstructured":"Abern MR, Larsen S, Levine LA. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie\u2019s disease. J Sex Med. 2012;9:288\u201395. Adding penile traction as a component of combination therapy in nonsurgical PD patients results in improved curvature and dose-dependent gains in penile length.","journal-title":"J Sex Med"},{"key":"459_CR38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jsm.12400","volume":"11","author":"JI Martinez-Salamanca","year":"2014","unstructured":"Martinez-Salamanca JI, Equi A, Moncada I, et al. Acute phase Peyronie\u2019s disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation. J Sex Med. 2014;11:506\u201315. This is the largest trial to date lending support for penile traction in acute phase PD patients. An early penile traction regimen significantly improves curvature, prevents disease progression, and can potentially reduce the need for surgery in motivated patients.","journal-title":"J Sex Med"},{"key":"459_CR39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ijir.2014.6","volume":"26","author":"U Cantoro","year":"2014","unstructured":"Cantoro U, Polito M, Catanzariti F, et al. Penile plication for Peyronie's disease: our results with mean follow-up of 103\u00a0months on 89 patients. Int J Impot Res. 2014;26:156\u20139. This recent report of long-term follow-up in PD patients treated with surgical plication shows durable correction of curvature and lasting improvement in sexual function.","journal-title":"Int J Impot Res"},{"key":"459_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-7796.115736","volume":"5","author":"I Lopes","year":"2013","unstructured":"Lopes I, Tomada N, Vendeira P. Penile corporoplasty with Yachia's technique for Peyronie's disease: Single center experience with 117 patients. Urol Ann. 2013;5:167\u201371.","journal-title":"Urol Ann"},{"key":"459_CR41","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/j.1743-6109.2012.02849.x","volume":"9","author":"J Rybak","year":"2012","unstructured":"Rybak J, Papagiannopoulos D, Levine L. A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie\u2019s disease: measure lengths and patient perceptions. J Sex Med. 2012;9:2396\u2013403. This small retrospective study shows that penile traction therapy leads to a mean length gain of 1.48\u00a0cm when used for penile rehabilitation after grafting procedures.","journal-title":"J Sex Med"},{"key":"459_CR42","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/jsm.12462","volume":"11","author":"AF Miranda","year":"2014","unstructured":"Miranda AF, Sampaio FJ. A Geometric model of plaque incision and graft for Peyronie's disease with geometric analyses of different techniques. J Sex Med. 2014;11:1546\u201353. A novel and reproducible penile model of PD is described. This model is used to compare the geometric and cosmetic results of various surgical techniques.","journal-title":"J Sex Med"},{"key":"459_CR43","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1111\/j.1464-410X.2012.11582.x","volume":"111","author":"PH Egydio","year":"2012","unstructured":"Egydio PH, Kuehhas FE, Sansalone S. Penile length and girth restoration in severe Peyronie\u2019s disease using circular and longitudinal grafting. BJUI. 2012;111:E213\u20139.","journal-title":"BJUI"},{"key":"459_CR44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/aja.2011.42","volume":"6","author":"S Sansalone","year":"2011","unstructured":"Sansalone S, Garaffa G, Djinovic R, et al. Long-term results of the surgical treatment of Peyronie\u2019s disease with Egydio\u2019s technique: a European multicentre study. Asian J Androl. 2011;6:842\u20135.","journal-title":"Asian J Androl"},{"key":"459_CR45","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1743-6109.2011.02299.x","volume":"8","author":"S Flores","year":"2011","unstructured":"Flores S, Choi J, Alex B, Mulhall JP. Erectile dysfunction after plaque incision and grafting: short-term assessment of incidence and predictors. J Sex Med. 2011;8:2031\u20137.","journal-title":"J Sex Med"},{"key":"459_CR46","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1464-410X.2004.05220.x","volume":"94","author":"PH Egydio","year":"2004","unstructured":"Egydio PH, Lucon AM, Arap S. A single relaxing incision to correct different types of penile curvature: surgical technique based on geometrical principles. BJU Int. 2004;94:1147\u201357.","journal-title":"BJU Int"},{"key":"459_CR47","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1743-6109.2011.02370.x","volume":"8","author":"LA Levine","year":"2011","unstructured":"Levine LA. Partial plaque excision and grafting (PEG) for Peyronie\u2019s disease. J Sex Med. 2011;8:1842\u20135.","journal-title":"J Sex Med"},{"key":"459_CR48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(17)32519-3","volume":"152","author":"SK Wilson","year":"1994","unstructured":"Wilson SK, Delk JR. A new treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol. 1994;152:1121\u20133.","journal-title":"J Urol"},{"key":"459_CR49","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1111\/j.1743-6109.2010.01971.x","volume":"7","author":"LA Levine","year":"2010","unstructured":"Levine LA, Benson J, Hoover C. Inflatable penile prosthesis placement in men with Peyronie's disease and drug-resistant erectile dysfunction: a single-center study. J Sex Med. 2010;7:3775\u201383.","journal-title":"J Sex Med"},{"key":"459_CR50","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/jsm.12009","volume":"10","author":"E Chung","year":"2013","unstructured":"Chung E, Solomon M, Deyoung L, Brock GB. Comparison between AMS 700\u2122 CX and Coloplast\u2122 Titan inflatable penile prosthesis for Peyronie's disease treatment and remodeling: clinical outcomes and patient satisfaction. J Sex Med. 2013;10:2855\u201360. This comparison of 3-piece IPP models reveals that both devices result in adequate straightening and device durability after manual modeling.","journal-title":"J Sex Med"},{"key":"459_CR51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/erd.12.92","volume":"10","author":"LW Trost","year":"2013","unstructured":"Trost LW, Mccaslin R, Linder B, et al. Long-term outcomes of penile prostheses for the treatment of erectile dysfunction. Expert Rev Med Devices. 2013;10:353\u201366.","journal-title":"Expert Rev Med Devices"},{"key":"459_CR52","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/j.1743-6109.2011.02285.x","volume":"8","author":"LA Levine","year":"2011","unstructured":"Levine LA, Rybak J. Traction therapy for men with shortened penis prior to penile prosthesis implantation: a pilot study. J Sex Med. 2011;8:2112\u20137.","journal-title":"J Sex Med"},{"key":"459_CR53","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ijir.2013.10","volume":"25","author":"O Kayigil","year":"2013","unstructured":"Kayigil O, Okulu E. The combination of penile revascularization surgery with penile corrective techniques as an alternative to prosthesis implantation in patients with Peyronie's disease having ED: preliminary results. Int J Impot Res. 2013;25:166\u201371. The first report of penile straightening combined with penile revascularization to treat patients with PD and ED. Although technically complex, this approach offers an alternative to IPP placement in select patients.","journal-title":"Int J Impot Res"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-014-0459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-014-0459-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-014-0459-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T21:50:01Z","timestamp":1565905801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-014-0459-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1007\/s11934-014-0459-5","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,7]]},"article-number":"459"}}